Wednesday, 17 September 2014

Merck Licenses Experimental Psoriasis Drug to Sun Pharma

Merck & Co Inc said it has licensed its experimental psoriasis drug to Indian generic maker Sun Pharmaceutical Industries Ltd for $80 million (Rs 480 crore at 1 dollar = 60 rupees).

















from NDTV News - Profit http://ift.tt/1BMixSe

No comments:

Post a Comment